It looks like Nissan won't be able to restart the production of the Navara and Terra in The Land of Smiles just yet.

Recently, the Japanese automaker announced that they have extended the temporary suspension of vehicle production at its factory in Thailand due to the COVID-19 pandemic.

In a statement, Nissan said that production suspension at Plant 2 in Samut Prakan will be extended from May 4, 2020, until May 31, 2020. Meanwhile, production at Plant 1 will continue to be adjusted to meet current demand levels.

Thai factory that makes Nissan Navara, Terra, extends suspension image

“Our goal is to resume normal business operations as soon as possible, but ensuring the safety and well-being of all our employees, their families, and Thai society is our priority right now given the COVID-19 pandemic,” said Ramesh Narasimhan, president of Nissan Thailand.

Narasimhan was previously the president of Nissan Philippines, Inc. 

Despite Plant 2 not being able to restart vehicle production, Nissan Thailand is confident that it has a sufficient supply of vehicles to meet customer demand. In addition, all Nissan dealerships in Thailand are still open and are committed to continuing providing quality service to all of its customers.

But to ensure the safety and well-being of both the customers and its employees, Nissan Thailand has implemented several preventive measures across all dealerships and service centers.

These include disinfecting the service center every 30 minutes, checking the temperature of all employees and customers when they enter the dealership, requiring staff to wear face masks at all times, providing alcohol throughout the premises, and the constant disinfection of vehicle touch-points like the steering wheel, gear shifter, seats, door handles, and console panels.

Currently, Thailand has 2,947 confirmed cases, 54 deaths, and 2,665 recoveries. With those figures. it looks like Thailand could be on its way to a swift recovery from the COVID-19 pandemic. Here's to hoping that the country will not suffer from the second wave of infections.